Clinical Trial Update: Proton Pump Inhibitors in Cirrhotic Patients

View source ↗

Summary

A completed clinical trial evaluating proton pump inhibitors in patients with liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Proton pump inhibitors (PPI) (proton pump inhibitors)

Snippet

Sponsor: National Liver Institute, Egypt | Conditions: Proton Pump Inhibitor Adverse Reaction, Liver Cirrhosis | Status: COMPLETED